NCT00346580View on ClinicalTrials.gov

The Effects of HIV Protease Inhibitors in Severe Sepsis

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Sepsis
Interventions
DRUG

Nelfinavir

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT00346580 - The Effects of HIV Protease Inhibitors in Severe Sepsis | Biotech Hunter | Biotech Hunter